Tumor angiogenesis;Angiogenèse tumorale

Bulletin du Cancer

Volumn 94, Issue SUPPL. 7, 2007, Pages

  Bikfalvi, Andreas ^a  

^a INSERM   (France)

Author keywords

Angiogenic switch; Angiopoietin; Angiostatin; Fibroblastic growth factors (FGF); Platelet factor 4; Thrombospondins endostatin; Vascular endothelial growth factors (VEGF)

Indexed keywords

ANGIOPOIETIN; ANGIOSTATIN; BEVACIZUMAB; FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IMC 1C11; PLATELET DERIVED GROWTH FACTOR; SORAFENIB; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VATALANIB;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; CANCER; CANCER CHEMOTHERAPY; CARCINOGENESIS; CLINICAL TRIAL; COLON CANCER; DRUG IDENTIFICATION; DRUG MECHANISM; HUMAN; LYMPHANGIOGENESIS; NEOVASCULARIZATION (PATHOLOGY); REVIEW; TUMOR; TUMOR CELL; VASCULAR TUMOR;

ANGIOPOIETINS; FIBROBLAST GROWTH FACTORS; HUMANS; LYMPHANGIOGENESIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 36248969295     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2007.0428     Document Type: Review

References (5)

1. Raffi S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells : novel targets for anti-angiogenesis therapy? Nat Rep Cancer 2002 ; 2 : 826-35.
2. Bikfalvi A, Bicknell R. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol Sci 2002 ; 23 : 576-82.
3. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005 ; 438 : 946-53.
4. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 2004 ; 36 : 827-35.
5. Autiero M, De Smet F, Claes F, Carmeliet P. Role of neural guidance signals in blood vessel navigation. Cardiovasc Res 2005 ; 65 : 629-38.